Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.
FEATURED PROJECTS

Evidence for the Increasing Role
of Natriuretic Peptides in the
Diagnosis and Management of Heart Failure

Register online at HEFDI.org

This webinar presented by healthcare professionals James L. Januzzi Jr., Beth T. Davidson, and Ann S. Laramee, discusses evidence for the utility of natriuretic peptide testing to improve outcome, and presents case studies on the management of heart failure after admission and discharge.

Complimentary CME & CE Credits. There is no charge for the program or certificate, but registration is required for the webinar, access to the slides, and online post-test CME assessment.

Planned and developed by Medavera, Inc. and supported by educational grants from Quidel and Quest Diagnostics, Inc.

THE MEDICAL NEWS
CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.... LONDON (Reuters) - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.... NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.... (Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, the company said on Wednesday.... (Reuters) - A U.S. appeals court on Wednesday vacated the conviction of the owner of a wholesale drug distributor accused of selling authentic Botox and other drugs with foreign labels, dealing another setback to the government, which has struggled at times to successfully prosecute similar such cases.... CHICAGO (Reuters) - As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.... CHICAGO (Reuters) - A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday.... ZURICH (Reuters) - Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on Wednesday.... (Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.... DUBLIN (Reuters) - An Irish parliamentary committee on Wednesday recommended that an abortion referendum due next year should offer the choice of allowing terminations with no restrictions up to 12 weeks into a pregnancy, a more liberal position than some had anticipated....